Massachusetts Financial Services’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6M Sell
574,685
-213
-0% -$5.75K 0.01% 702
2026
Q1
$10.4M Buy
574,898
+94,755
+20% +$1.81M ﹤0.01% 723
2025
Q4
$10.4M Sell
480,143
-41,668
-8% -$1.19M ﹤0.01% 711
2025
Q3
$17M Buy
521,811
+76,282
+17% +$2.82M 0.01% 651
2025
Q2
$15.8M Sell
445,529
-1,824,735
-80% -$59.1M 0.01% 644
2025
Q1
$77M Buy
2,270,264
+6,708
+0.3% +$241K 0.03% 413
2024
Q4
$73.7M Sell
2,263,556
-11,602
-0.5% -$481K 0.02% 422
2024
Q3
$111M Buy
2,275,158
+314,449
+16% +$16.7M 0.03% 374
2024
Q2
$86.8M Buy
1,960,709
+69,913
+4% +$3.23M 0.03% 393
2024
Q1
$106M Sell
1,890,796
-94,030
-5% -$5.67M 0.03% 376
2023
Q4
$119M Buy
1,984,826
+117,794
+6% +$7.46M 0.04% 349
2023
Q3
$125M Buy
1,867,032
+212,327
+13% +$14.7M 0.04% 327
2023
Q2
$114M Buy
1,654,705
+141,479
+9% +$9.24M 0.04% 345
2023
Q1
$73M Buy
1,513,226
+489,217
+48% +$23.9M 0.03% 395
2022
Q4
$51.1M Buy
+1,024,009
New +$49.6M 0.02% 436

Other funds holding LEGN

Massachusetts Financial Services's LEGN Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Legend Biotech (LEGN) stake by 0.04% in Q2 2026, selling an estimated $5.75K and leaving 574,685 shares worth $16.6M. The position accounts for 0.01% of the portfolio, ranked #702.

Massachusetts Financial Services first reported a position in LEGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $125M in Q3 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Massachusetts Financial Services held 574,685 shares of Legend Biotech worth $16.6M as of Q2 2026.
  • Massachusetts Financial Services sold 213 Legend Biotech shares in Q2 2026, an estimated $5.75K.
  • Legend Biotech made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #702 holding.
  • Massachusetts Financial Services first reported a position in Legend Biotech in Q4 2022 and has held it in 15 quarters since.
  • Massachusetts Financial Services's Legend Biotech position peaked at $125M in Q3 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.